Out-of-pocket costs continue to increase for patients who must buy commonly prescribed drugs to treat these five neurological ...

The causal relationship of liver disease to neuropathy has been questioned. This study was designed to evaluate the incidence and character of peripheral neuropathy in patients with liver cirrhosis.

A team of international researchers including those from the University of Adelaide have taken a well-known chemical reaction ...

In addition, these factors also stimulate inflammation-related damage to the nervous system, contributing to ...

Luckily, multiple treatments exist that can help you manage the condition. Medications such as mood stabilizers, antipsychotics, and benzodiazepines can be used alone or in combination with other ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN) ...

Although IPD is thought classically to spare the peripheral nervous system ... to reduce MMA levels and prevent neuropathy. Further studies, including treatment trials, seem warranted.

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat advanced solid tumors and chemotherapy-induced peripheral neuropathy ...

A person battling multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, but by 2021 that ...

Vertex Pharmaceuticals Incorporated VRTX reported adjusted earnings of $4.38 per share for the third quarter of 2024, ...

Dementia treatment is more than just medication. It can include lifestyle changes, multimodal therapy, and environmental management, as well. Your dementia treatment plan will depend on underlying ...

Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.